Dianabiotech

2 known investors

DIANA Biotechnologies develops PCR and RT-PCR reagents, custom oligonucleotide synthesis, monoclonal antibodies, ultrasensitive sepsis diagnostics, and kinase inhibitor profiling services for diagnostic and academic laboratories. The company relies on its PCR expertise and proprietary DIANA technology, with products available across 18 European countries.

BiotechHealthtechMedical Devices